{"name":"Minghui Pharmaceutical (Hangzhou) Ltd","slug":"minghui-pharmaceutical-hangzhou-ltd","ticker":"","exchange":"","domain":"minghuihangzhou.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":7,"colorKey":"oncology","drugs":[{"name":"MHB018A injection","genericName":"MHB018A injection","slug":"mhb018a-injection","indication":"Other","status":"phase_3"},{"name":"MH004 Ointment","genericName":"MH004 Ointment","slug":"mh004-ointment","indication":"Other","status":"phase_3"},{"name":"MHB039A for Injection","genericName":"MHB039A for Injection","slug":"mhb039a-for-injection","indication":"Other","status":"phase_2"},{"name":"Furmonertinib","genericName":"Furmonertinib","slug":"furmonertinib","indication":"Other","status":"phase_3"},{"name":"MH004 1.0% Ointment","genericName":"MH004 1.0% Ointment","slug":"mh004-1-0-ointment","indication":"Other","status":"phase_1"},{"name":"MHB036C for Injection","genericName":"MHB036C for Injection","slug":"mhb036c-for-injection","indication":"Other","status":"phase_2"},{"name":"MHB039A","genericName":"MHB039A","slug":"mhb039a","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"MHB018A injection","genericName":"MHB018A injection","slug":"mhb018a-injection","phase":"phase_3","mechanism":"MHB018A injection's mechanism is not publicly available.","indications":[],"catalyst":""},{"name":"MH004 Ointment","genericName":"MH004 Ointment","slug":"mh004-ointment","phase":"phase_3","mechanism":"MH004 is a topical ointment formulation designed to treat dermatological conditions through localized therapeutic action.","indications":[],"catalyst":""},{"name":"MHB039A for Injection","genericName":"MHB039A for Injection","slug":"mhb039a-for-injection","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Furmonertinib","genericName":"Furmonertinib","slug":"furmonertinib","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"MH004 1.0% Ointment","genericName":"MH004 1.0% Ointment","slug":"mh004-1-0-ointment","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"MHB036C for Injection","genericName":"MHB036C for Injection","slug":"mhb036c-for-injection","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"MHB039A","genericName":"MHB039A","slug":"mhb039a","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxNTVNXR2VFdWxtSUhGd2syTlVDcHNjYVZZNnNKVEs2dTFKa3lPdEVHVzhjT29OYm1aY3VLTllNSTdzZm8xcnhzcXdxcGhGbTY2TE9EMkdYTjgxSzZvWUlWaldXb1hoMmtoR1FYTlBlR0hrWHY4Q1FyQWZFOF9QaTI2eW85WTZLT0JmTnVyYnVsZnpQVFRkTml0UlZVX09NQ29FcVlPRzJXZGFienFCTWJsNU9fUkU4UlliRkZNQU4yN0FTVm9vWGxuX0JBVzcxXzYwZTRqN01iQkRQMlk2WHJEdGJDTE4tVDJkT3pwQXU5dmJ0RFdPZVhweURib2NIMzVHZUJ1VjNreWtGNUc0Y3JxLThHSUhaUWp0MXZtbFkzSEhVVUlPS0JrOQ?oc=5","date":"2025-10-16","type":"trial","source":"GlobeNewswire","summary":"Thyroid Eye Disease Clinical Trial Pipeline Gains Momentum: - GlobeNewswire","headline":"Thyroid Eye Disease Clinical Trial Pipeline Gains Momentum:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQQzk2SGl2QUFJWVFGajlaMV9vc290OU1JUVc2d1VKOExIRzlwR0VBczJ2WXFMRkN5WWlZZG5JYTliTmQ1b1lId1EwV0F4UUpDSy1weU1aOVZtLVNDX3VKNjdpdXY3ZXVwcEFWdGlBczhTbWZXNXYyQm9iUm1yUVFYaUg5VHhfMHpuWkhPdVpQMmZvVXlwc3F4SV9WNV93SjF4WHQ3Sg?oc=5","date":"2025-08-12","type":"pipeline","source":"BioWorld News","summary":"Minghui closes $131M pre-IPO round for PD-1/VEGF antibody, ADCs - BioWorld News","headline":"Minghui closes $131M pre-IPO round for PD-1/VEGF antibody, ADCs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1BdjVDOTIyOXlnVEtlVXhRTGs2cWt6bGNzYVE4ei05UnpvY2s5dk1KSXpERVpDU2s3cEpKYjlOcHhXbXp2X004REU3YV9XNzN4UTNxX3l0S1hObm1LSHNRSEhSRzJqNFdPSkZDLUJpSURVMkdDaHRN?oc=5","date":"2025-05-12","type":"pipeline","source":"Pharmaceutical Technology","summary":"Minghui and Qilu to advance MHB088C in Greater China - Pharmaceutical Technology","headline":"Minghui and Qilu to advance MHB088C in Greater China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQM0x0VDlUdVFRa2lXdHIwOGd3eEwxZUZ0U1BaS2M1dklRZF9zV29YMTBIX211cDRFb0dTeE9Od2tERU5jMjc5bVdCLVI0R0IyZWI3LVRfMGppbFVuNzhOZHl0VFNpMFAxcU43RjFXTDFBN0tyWV9KVVUxOFMwNmtLV2hFSWIybzJKTjhNRkp3YlV3QS1manNFYk5CTXF1NlowdGNhVVNqazNvUjVSdlhaY2Rn?oc=5","date":"2023-01-10","type":"pipeline","source":"BioWorld News","summary":"Minghui Pharmaceutical divulges new antibody-drug conjugates for cancer - BioWorld News","headline":"Minghui Pharmaceutical divulges new antibody-drug conjugates for cancer","sentiment":"neutral"}],"patents":[],"drugCount":7,"phaseCounts":{"phase_3":3,"phase_2":2,"phase_1":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}